WHO ICTRP trial
efficacy and adverse events in 2 different SLIT tablets for house dust mite…
JPRN-UMIN000021195 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000021195 |
|---|---|
| Public title | efficacy and adverse events in 2 different SLIT tablets for house dust mite allergy |
| Scientific title | efficacy and adverse events in 2 different SLIT tablets for house dust mite allergy - efficacy and safety in SLIT tablets |
| Primary sponsor | Otorhinolaryngology, Saitama Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | house dust mite - nasal allergy |
| Interventions | actair treatment group miticure treatment group control |
| Registration date | Jan 4, 2017 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: